Patents Assigned to The Salk Institute for Biologicial Studies
  • CRFR2 selective ligands
    Patent number: 7141546
    Abstract: CRF peptide analogs that bind to CRFR2 with an affinity far greater than they bind to CRFR1. These analogs exhibit CRF antagonist activity, and they can be based upon the native structures of sauvagine, CRF, and urocortin.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: November 28, 2006
    Assignee: The Salk Institute for Biologicial Studies
    Inventors: Jean E. F. Rivier, Wylie W. Vale, Marilyn H. Perrin, Jozsef Gulyas, Dean A. Kirby